...
首页> 外文期刊>Antimicrobial agents and chemotherapy. >Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.
【24h】

Characterization and nucleotide sequence of a Klebsiella oxytoca cryptic plasmid encoding a CMY-type beta-lactamase: confirmation that the plasmid-mediated cephamycinase originated from the Citrobacter freundii AmpC beta-lactamase.

机译:编码CMY型β-内酰胺酶的产酸克雷伯菌隐性质粒的表征和核苷酸序列:证实质粒介导的头孢菌素酶起源于弗氏柠檬酸杆菌AmpCβ-内酰胺酶。

获取原文
获取原文并翻译 | 示例
           

摘要

Plasmid pTKH11, originally obtained by electroporation of a Klebsiella oxytoca plasmid preparation into Escherichia coli XAC, expressed a high level of an AmpC-like beta-lactamase. The enzyme, designated CMY-5, conferred resistance to extended-spectrum beta-lactams in E. coli; nevertheless, the phenotype was cryptic in the K. oxytoca donor. Determination of the complete nucleotide sequence of pTKH11 revealed that the 8,193-bp plasmid encoded seven open reading frames, including that for the CMY-5 beta-lactamase (blaCMY-5). The blaCMY-5 product was similar to the plasmidic CMY-2 beta-lactamase of K. pneumoniae and the chromosomal AmpC of Citrobacter freundii, with 99.7 and 97.0% identities, respectively; there was a substitution of phenylalanine in CMY-5 for isoleucine 105 in CMY-2. blaCMY-5 was followed by the Blc and SugE genes of C. freundii, and this cluster exhibited a genetic organization identical to that of the ampC region on the chromosome of C. freundii; these results confirmed that C. freundii AmpC was the evolutionary origin of the plasmidic cephamycinases. In the K. oxytoca host, the copy number of pTKH11 was very low and the plasmid coexisted with plasmid pNBL63. Analysis of the replication regions of the two plasmids revealed 97% sequence similarity in the RNA I transcripts; this result implied that the two plasmids might be incompatible. Incompatibility of the two plasmids might explain the cryptic phenotype of blaCMY-5 in K. oxytoca through an exclusion effect on pTKH11 by resident plasmid pNBL63.
机译:最初通过将产酸克雷伯氏菌质粒制备物电穿孔到大肠杆菌XAC中获得的质粒pTKH11表达了高水平的AmpC样β-内酰胺酶。命名为CMY-5的酶赋予了大肠杆菌对广谱β-内酰胺的抗性。然而,该表型在催产克氏杆菌供体中是隐性的。确定pTKH11的完整核苷酸序列后发现,该8,193 bp质粒编码了七个开放阅读框,包括CMY-5β-内酰胺酶(blaCMY-5)的可读框。 blaCMY-5产物类似于肺炎克雷伯菌的质粒CMY-2β-内酰胺酶和弗氏柠檬酸杆菌的染色体AmpC,分别具有99.7%和97.0%的同一性。 CMY-5中的苯丙氨酸被CMY-2中的异亮氨酸105取代。 blaCMY-5之后是弗氏梭菌的Blc和SugE基因,该簇的遗传组织与弗氏梭菌染色体上的ampC区相同。这些结果证实弗氏梭菌AmpC是质粒头孢菌素酶的进化起源。在催产假单胞菌宿主中,pTKH11的拷贝数非常低,该质粒与质粒pNBL63共存。对这两个质粒复制区的分析显示,RNA I转录本中的序列相似性为97%。该结果暗示两个质粒可能不相容。这两个质粒的不相容性可能通过驻在质粒pNBL63对pTKH11的排斥作用来解释隐球菌中blaCMY-5的隐型表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号